Reata Pharmaceuticals: Q3 Earnings Insights

Reata Pharmaceuticals RETA reported its Q3 earnings results on Monday, November 8, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Reata Pharmaceuticals their estimated earnings by 41.2%, reporting an EPS of $-1.27 versus an estimate of $-2.16, which surprised analysts.

Revenue was up $5,990,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.76, which was followed by a 18.12% drop in the share price the next day.

Here's a look at Reata Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.